Literature DB >> 19231618

Major achievements in hepatocellular carcinoma.

Jordi Bruix1, Josep M Llovet.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19231618     DOI: 10.1016/S0140-6736(09)60381-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  110 in total

1.  Surgical resection for advanced hepatocellular carcinoma according to Barcelona Clinic Liver Cancer (BCLC) staging.

Authors:  Tian Yang; Chuan Lin; Jian Zhai; Song Shi; Min Zhu; Nan Zhu; Jun-Hua Lu; Guang-Shun Yang; Meng-Chao Wu
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-10       Impact factor: 4.553

2.  Prognostic Significance of Treatment Strategies for the Recurrent Hepatocellular Carcinomas After Radical Resection.

Authors:  Ryo Saito; Hidetake Amemiya; Naohiro Hosomura; Hiromichi Kawaida; Suguru Maruyama; Hiroki Shimizu; Shinji Furuya; Hidenori Akaike; Yoshihiko Kawaguchi; Makoto Sudo; Shingo Inoue; Hiroshi Kono; Daiduke Ichikawa
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

3.  Hepatocellular carcinoma: the place of new medical therapies.

Authors:  Markus Peck-Radosavljevic
Journal:  Therap Adv Gastroenterol       Date:  2010-07       Impact factor: 4.409

Review 4.  Transplant benefit for patients with hepatocellular carcinoma.

Authors:  Alessandro Vitale; Michael Volk; Umberto Cillo
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

5.  Recurrence rates and factors for recurrence after radiofrequency ablation combined with transarterial chemoembolization for hepatocellular carcinoma: a retrospective cohort study.

Authors:  Jeong Han Kim; Hyung Joon Yim; Kwang Gyun Lee; Seung Young Kim; Eun Suk Jung; Young Kul Jung; Ji Hoon Kim; Yeon Seok Seo; Jong Eun Yeon; Hong Sik Lee; Soon Ho Um; Kwan Soo Byun; Ho Sang Ryu
Journal:  Hepatol Int       Date:  2011-07-05       Impact factor: 6.047

Review 6.  Magnetic resonance imaging of the cirrhotic liver: An update.

Authors:  Agnes Watanabe; Miguel Ramalho; Mamdoh AlObaidy; Hye Jin Kim; Fernanda G Velloni; Richard C Semelka
Journal:  World J Hepatol       Date:  2015-03-27

7.  Outcome of hepatectomy for hepatocellular carcinoma in elderly patients with portal hypertension.

Authors:  Shozo Mori; Junji Kita; Takayuki Shimizu; Masato Kato; Mitsugi Shimoda; Keiichi Kubota
Journal:  Int Surg       Date:  2014 Mar-Apr

8.  SALL4 immunoreactivity predicts prognosis in Western hepatocellular carcinoma patients but is a rare event: a study of 236 cases.

Authors:  Ta-Chiang Liu; Neeta Vachharajani; William C Chapman; Elizabeth M Brunt
Journal:  Am J Surg Pathol       Date:  2014-07       Impact factor: 6.394

9.  Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinoma.

Authors:  Masato Tsuchiya; Joel S Parker; Hiroshi Kono; Masanori Matsuda; Hideki Fujii; Ivan Rusyn
Journal:  Mol Cancer       Date:  2010-04-09       Impact factor: 27.401

10.  A human anti-c-Met Fab fragment conjugated with doxorubicin as targeted chemotherapy for hepatocellular carcinoma.

Authors:  Ximin Chen; Guipeng Ding; Qihe Gao; Jian Sun; Qianqian Zhang; Lijian Du; Zhenning Qiu; Changjun Wang; Feng Zheng; Bowang Sun; Jian Ni; Zhenqing Feng; Jin Zhu
Journal:  PLoS One       Date:  2013-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.